Magnetic Vibration Microrobots for Targeted Cancer Cell Apoptosis

This technology has the potential for targeted, single-cell treatment by utilizing low-frequency vibration to induce apoptosis, enhancing treatment specificity and safety.

Technology

Apoptosis is programmed cell death and therapies for cancer often aim to reactivate this natural process in tumor cells to eliminate them. However in the quest to develop cancer treatments that selectively induce apoptosis in cancer cells the hurdle is to spare healthy tissue. Mechanomedicine is an emerging field of medicine that uses mechanotrandsuction to improve health and is gaining interest for the treatment of cancer. There is emerging evidence that mechanotrasduction can induce apoptosis. However traditional high-frequency vibration techniques have been limited by their detrimental effects on healthy cells, necessitating a more refined approach. To help address these hurdles, UD Researchers have developed a method for inducing cell apoptosis through magnetic vibration. Controlled via a computer, the system sends a pulse width modulated signal to electromagnetics, targeting magnetic microspheres absorbed by cancer cells. Over time, the constant exposure to the vibrational magnetic field results in apoptosis. The University of Delaware’s approach is distinguished by its use of modulated signals transmitted to biocompatible micro-size magnetic particles or microrobots, enabling targeted, single-cell treatment with low-frequency vibration. This system can be customized for various microscale tasks, including diagnostics, cell sorting, manipulation, and targeted drug delivery. This technology has the potential for targeted, single-cell treatment by utilizing low-frequency vibration to induce apoptosis, enhancing treatment specificity and safety. This technology is both non-invasive and has minimal side effects.

Benefits

  • Targeted, single cell treatment of cancer.
  • Non-invasive
  • Induces apoptosis and not necrosis.

Applications

  • Cancer treatment.
  • Drug delivery for cancer therapy.